Drugs / methyl-D9-choline
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01807910 | Oct 2013 → Oct 2017 | NAFLD1, obesity disorder | Vanderbilt University | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | methyl-D9-choline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01807910 ↗ |